In this study, we assessed inflammation indicator values including FAR, fibrinogen-to-prealbumin ratio (FPR), NLR, platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and prognostic nutritional index (albumin + 5 × lymphocyte count; PNI) in early-stage PC, healthy controls (HC), and other pancreatic tumors (OPT), with the aim of exploring whether inflammation indicators could be used as markers for the diagnosis of early-stage PC. The gene discussed is ALB; the disease is pancreatic neoplasm.